Revolve is building the world’s only surgical robot designed for every operating room. Its simple yet powerful design makes it the only robot that can service the 1M+ abdominal surgeries performed outside of hospitals in the US every year.
Revolve Surgical is a Y Combinator company in the Summer 2021 batch. Its directory entry describes it as: Surgical robotics for every operating room. The founders listed are Peter Francis (Founder), Matthew Kang (Founder) (Y Combinator directory entry, August 10, 2021).
Sell to companies like Revolve Surgical? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2021-08-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Revolve Surgical.
Free to see. No signup.
More on Revolve Surgical and the records around it.
Same batch, Healthcare first.
Get an email when Revolve Surgical changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Revolve Surgical raises, hires or launches. No email unless you switch it on.
Watch Revolve Surgical →Get the full cited report on Revolve Surgical
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Revolve Surgical: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Revolve is building the world’s only surgical robot designed for every operating room. Its simple yet powerful design makes it the only robot that can service the 1M+ abdominal surgeries performed outside of hospitals in the US every year.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Revolve Surgical: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Revolve Surgical covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Revolve SurgicalYou get an alert in MentionFox the next time this company shows up.
If you're behind Revolve Surgical: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for Revolve Surgical. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-revolve-surgical